News

New grants for MazeBio, Akteon, Larmor and HelixScreen – two at SV

Published:02.10.26 — EPFL's School of Life Sciences will be involved in two of the four promising startup projects, MazeBio and HelixScreen; the others are Akteon and Larmor. All are supported by the EPFL Startup Launchpad and are taking the next steps towards bringing their technologies to market. MazeBio and Akteon have each received a CHF 30,000 Ignition Grant, while Larmor and HelixScreen have each been awarded a CHF 100,000 Innogrant. Spanning AI-powered drug discovery, compact flow cytometry, fusion energy and personalised cancer treatment, the four projects are addressing challenges across healthcare, biotechnology and energy, turning cutting-edge EPFL research into technologies with the potential for real-world impact.

15 women from EPFL recognized in Switzerland's Top 100 Women in AI

Published:28.09.26 — Fifteen women from across EPFL are being featured in the 2026 Top 100+ Women in AI, Data & Robotics report, celebrating their engagement and contribution to Switzerland’s rapidly evolving AI ecosystem. 

An appointment and a promotion at the School of Life Sciences

Published:28.09.26 — The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL. In the School of Life Sciences, Dr Lindsey Salay is appointed Tenure Track Assistant Professor, and Professor Matteo Dal Peraro is promoted to Full Professor.

Helping bladder cells to clear urinary infections

Published:28.09.26 — Researchers at EPFL have identified how an established treatment for recurrent urinary tract infections strengthens the bladder’s own defenses while helping antibiotics reach bacteria hidden inside its cells.

Bart Deplancke, new Dean of the School of Life Sciences

Published:24.09.26 — On the recommendation of the selection committee, the Executive Board has appointed Bart Deplancke as Dean of the School of Life Sciences (SV) for a four-year term starting January 1, 2027.